4.91
price down icon0.41%   -0.02
after-market 시간 외 거래: 4.94 0.03 +0.61%
loading
전일 마감가:
$4.93
열려 있는:
$4.83
하루 거래량:
5.71M
Relative Volume:
1.40
시가총액:
$1.16B
수익:
$251.85M
순이익/손실:
$-72.58M
주가수익비율:
-15.67
EPS:
-0.3134
순현금흐름:
$-63.80M
1주 성능:
-6.48%
1개월 성능:
-8.40%
6개월 성능:
-28.74%
1년 성능:
-32.74%
1일 변동 폭
Value
$4.675
$5.00
1주일 범위
Value
$4.675
$5.265
52주 변동 폭
Value
$4.32
$9.33

Ardelyx Inc Stock (ARDX) Company Profile

Name
명칭
Ardelyx Inc
Name
전화
510-745-7047
Name
주소
34175 ARDENWOOD BLVD., FREMONT, CA
Name
직원
267
Name
트위터
@ardelyx
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
ARDX's Discussions on Twitter

ARDX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ARDX
Ardelyx Inc
4.91 1.16B 251.85M -72.58M -63.80M -0.3134
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Ardelyx Inc Stock (ARDX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-07 재개 Ladenburg Thalmann Buy
2025-03-04 개시 BTIG Research Buy
2024-11-11 다운그레이드 H.C. Wainwright Buy → Neutral
2024-07-02 다운그레이드 Piper Sandler Overweight → Neutral
2024-04-05 개시 Leerink Partners Outperform
2023-12-18 개시 Raymond James Strong Buy
2023-09-07 개시 H.C. Wainwright Buy
2023-08-25 업그레이드 Cantor Fitzgerald Neutral → Overweight
2023-03-03 업그레이드 Wedbush Neutral → Outperform
2022-11-17 업그레이드 Piper Sandler Neutral → Overweight
2022-05-06 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2021-12-01 업그레이드 Ladenburg Thalmann Neutral → Buy
2021-10-14 다운그레이드 Ladenburg Thalmann Buy → Neutral
2021-07-21 다운그레이드 Jefferies Buy → Hold
2021-07-20 다운그레이드 Piper Sandler Overweight → Neutral
2021-07-20 다운그레이드 Wedbush Outperform → Neutral
2021-03-23 개시 Wedbush Outperform
2021-01-06 개시 Cantor Fitzgerald Overweight
2020-10-20 재개 Citigroup Buy
2020-02-18 재개 Jefferies Buy
2020-02-12 개시 Citigroup Buy
2020-02-10 개시 Cowen Outperform
2019-04-08 개시 Piper Jaffray Overweight
2018-08-24 개시 Jefferies Buy
2018-03-19 재개 Leerink Partners Outperform
2017-11-29 재확인 Citigroup Buy
2017-11-22 재확인 Ladenburg Thalmann Buy
2017-10-17 재개 Leerink Partners Outperform
2016-03-31 개시 Ladenburg Thalmann Buy
2016-03-09 개시 Cantor Fitzgerald Buy
2016-03-03 개시 Citigroup Buy
모두보기

Ardelyx Inc 주식(ARDX)의 최신 뉴스

pulisher
04:12 AM

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings - The Manila Times

04:12 AM
pulisher
04:03 AM

First-in-Class Kidney Disease Drug XPHOZAH Reveals Breakthrough Clinical Results - Stock Titan

04:03 AM
pulisher
11:31 AM

Commit To Purchase Ardelyx At $4, Earn 20.5% Annualized Using Options - Nasdaq

11:31 AM
pulisher
Mar 28, 2025

Institutional owners may take dramatic actions as Ardelyx, Inc.'s (NASDAQ:ARDX) recent 6.4% drop adds to one-year losses - simplywall.st

Mar 28, 2025
pulisher
Mar 27, 2025

How to Take Advantage of moves in (ARDX) - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 25, 2025

Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire

Mar 25, 2025
pulisher
Mar 20, 2025

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - Marketscreener.com

Mar 20, 2025
pulisher
Mar 19, 2025

ARDELYX INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Mar 19, 2025
pulisher
Mar 17, 2025

Trading (ARDX) With Integrated Risk Controls - news.stocktradersdaily.com

Mar 17, 2025
pulisher
Mar 13, 2025

Ardelyx honors inaugural Derek Forfang award winners By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth By Investing.com - Investing.com UK

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx honors inaugural Derek Forfang award winners - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Five Champions of Kidney Disease Advocacy Receive Groundbreaking Ardelyx Recognition - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Insider Buying: David Mott Acquires Shares of Ardelyx Inc (ARDX) - GuruFocus.com

Mar 12, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains $8 target on Ardelyx shares amid uncertainty By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains $8 target on Ardelyx shares amid uncertainty - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

8,020 Shares in Ardelyx, Inc. (NASDAQ:ARDX) Bought by SBI Securities Co. Ltd. - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Ardelyx at Leerink Global Healthcare Conference: Navigating Challenges and Opportunities By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 11, 2025

Ardelyx at Leerink Global Healthcare Conference: Navigating Challenges and Opportunities - Investing.com India

Mar 11, 2025
pulisher
Mar 10, 2025

High Growth Tech Stocks In The US With Promising Potential - Simply Wall St

Mar 10, 2025
pulisher
Mar 09, 2025

Ardelyx (NASDAQ:ARDX) Earns “Buy” Rating from LADENBURG THALM/SH SH - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Ardelyx CEO Michael Raab sells $223,198 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Scotiabank sets $15 target for Ardelyx stock, sees growth potential - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Scotiabank sets $15 target for Ardelyx stock, sees growth potential By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Ardelyx, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Cantor Fitzgerald Predicts Ardelyx FY2025 Earnings - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Ardelyx (NASDAQ:ARDX) Raised to Strong-Buy at Cantor Fitzgerald - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Rhumbline Advisers Purchases 6,070 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Ardelyx (NASDAQ:ARDX) Coverage Initiated by Analysts at BTIG Research - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

BTIG sets Ardelyx stock Buy rating, $14 price target - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

BTIG sets Ardelyx stock Buy rating, $14 price target By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

BTIG Initiates Ardelyx at Buy With $14 Price Target -March 04, 2025 at 07:10 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

BTIG initiates Ardelyx with a Buy, sees attractive entry point after pullback - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Mar 04, 2025
pulisher
Mar 03, 2025

Ardelyx, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 03, 2025

Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 02, 2025

Reviewing Q32 Bio (NASDAQ:QTTB) & Ardelyx (NASDAQ:ARDX) - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Shareholders That Lost Money on Ardelyx, Inc. (ARDX) Should Contact Levi & Korsinsky About Pending Class ActionARDX - ACCESS Newswire

Mar 01, 2025
pulisher
Mar 01, 2025

Undercovered Dozen: Ardelyx, Aviva, Nutrien, Heartland Express + - Seeking Alpha

Mar 01, 2025
pulisher
Feb 28, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Los Angeles Capital Management LLC Has $2.38 Million Stock Position in Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Ardelyx (NASDAQ:ARDX) Stock Price Up 5.3% on Insider Buying Activity - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Shareholders of Ardelyx, Inc. Should Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Levi & Korsinsky Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 27, 2025

Shareholders that lost money on Ardelyx, Inc. (ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

Insider Buying: Ardelyx, Inc. (NASDAQ:ARDX) Director Buys 77,729 Shares of Stock - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Wedbush Estimates Ardelyx's FY2029 Earnings (NASDAQ:ARDX) - MarketBeat

Feb 27, 2025

Ardelyx Inc (ARDX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
자본화:     |  볼륨(24시간):